tiprankstipranks
SpectrumDNA Inc (SPXA)
OTHER OTC:SPXA
US Market

SpectrumDNA (SPXA) Income Statement

13 Followers

SpectrumDNA Income Statement

Last quarter (Q ), SpectrumDNA's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q, SpectrumDNA's net income was $-6.80K. See SpectrumDNA’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 10Dec 09Dec 08Dec 07
Total Revenue
$ 258.85K$ 141.25K$ 149.80K$ 67.75K$ 53.95K
Cost of Revenue
$ 4.45K$ 4.08K$ 68.93K$ 97.67K$ 43.95K
Gross Profit
$ 254.40K$ 137.17K$ 80.87K$ -29.92K$ 10.00K
Operating Expense
$ 1.77M$ 2.06M$ 2.46M$ 2.57M$ 1.92M
Operating Income
$ -1.51M$ -1.92M$ -2.38M$ -2.60M$ -1.91M
Net Non Operating Interest Income Expense
$ -1.99K$ -48.86K$ -64.89K$ 36.98K$ 63.03K
Other Income Expense
$ -25.55K$ 6.35K$ 9.00K-$ 12.77K
Pretax Income
$ -1.51M$ -1.97M$ -2.43M$ -2.56M$ -1.83M
Tax Provision
-$ 0.00$ 0.00$ 0.00$ 0.00
Earnings From Equity Interest Net Of Tax
-----
Net Income Common Stockholders
$ -1.03M$ -1.97M$ -2.43M$ -2.56M$ -1.83M
Basic EPS
$ -0.01$ -0.03$ -0.05$ -0.05$ -0.04
Diluted EPS
$ -0.01$ -0.03$ -0.05$ -0.05$ -0.04
Basic Average Shares
$ 277.63M$ 67.80M$ 49.11M$ 48.66M$ 47.13M
Diluted Average Shares
$ 277.63M$ 67.80M$ 49.11M$ 48.66M$ 47.13M
Dividend Per Share
-----
Total Operating Income As Reported
-----
Reported Normalized Basic E P S
-----
Reported Normalized Diluted E P S
-----
Rent Expense Supplemental
-----
Total Expenses
$ 1.77M$ 2.07M$ 2.53M$ 2.66M$ 1.96M
Net Income From Continuing And Discontinued Operation
$ -1.03M$ -1.97M$ -2.43M$ -2.56M$ -1.83M
Normalized Income
$ -1.51M$ -1.97M$ -2.44M$ -2.56M$ -1.85M
Interest Expense
$ 2.38K$ 50.71K$ 66.87K$ 0.00-
EBIT
$ -1.51M$ -1.92M$ -2.37M$ -2.56M$ -1.91M
EBITDA
$ -1.50M$ -1.90M$ -2.29M$ -2.46M$ -1.87M
Currency in USD

SpectrumDNA Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis